The effect of two different heart-lung machines, Twin-Pulse Life Support and standard used heart-lung machine, on the systemic inflammation and pattern of microvascular blood flow. A prospective randomised clinical trial.

The effect of two different heart-lung machines, Twin-Pulse Life Support and standard used heart-lung machine, on the systemic inflammation and pattern of microvascular blood flow. A prospective randomised clinical trial. - The effect of TPLS compared to standard HLM

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30555

Enrollment

Registered

2007-08-08

Start date

2006-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery atherosclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: primary CABG age: 55 - 75 years left ventricular ejection fraction > 45%

Exclusion criteria

Exclusion criteria: renal dialysis history of stroke pulmonary insufficiency

Design outcomes

Primary

Measure	Time frame
Systemic inflammatory response	—

Secondary

Measure	Time frame
Analyses of the effect of Twin-PulseLifeSupport on microvascular blood flow	—

Countries

Netherlands

Outcome results